...
首页> 外文期刊>Journal of diabetes research. >Evaluation of Aldose Reductase, Protein Glycation, and Antioxidant Inhibitory Activities of Bioactive Flavonoids in Matricaria recutita L. and Their Structure-Activity Relationship
【24h】

Evaluation of Aldose Reductase, Protein Glycation, and Antioxidant Inhibitory Activities of Bioactive Flavonoids in Matricaria recutita L. and Their Structure-Activity Relationship

机译:醛糖醛植物生物活性黄酮类醛糖还原酶,蛋白质糖化和抗氧化抑制活性的评价及其结构 - 活性关系

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The inhibitory activities of Matricaria recutita L. 70% methanol extract were evaluated by isolating and testing 10 of its compounds on rat lens aldose reductase (RLAR), advanced glycation end products (AGEs), and 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging. Among these compounds, apigenin-7-O-beta-D-glucoside, luteolin-7-O-beta-D-glucoside, apigenin-7-O-beta-D-glucuronide, luteolin-7-O-beta-D-glucuronide, 3,5-O-di-caffeoylquinic acid, apigenin, and luteolin showed potent inhibition, and their IC50 values in RLAR were 4.25, 1.12, 1.16, 0.85, 0.72, 1.72, and 1.42 mu M, respectively. Furthermore, these compounds suppressed sorbitol accumulation in rat lens under high-glucose conditions, demonstrating their potential to prevent sorbitol accumulation ex vivo. Notably, luteolin-7-O-beta-D-glucuronide and luteolin showed antioxidative as well as AGE-inhibitory activities (IC50 values of these compounds in AGEs were 3.39 and 6.01 mu M). These results suggest that the M. recutita extract and its constituents may be promising agents for use in the prevention or treatment of diabetic complications.
机译:Matricaria Recutita L. 70%甲醇提取物的抑制作用通过在大鼠晶状体醛糖还原酶(RLAR),先进的糖糖末端产物(年龄)和2,2-二苯基-1-Picrylazyl( DPPH)激进清除。在这些化合物中,Apigenin-7-O-Beta-D-葡糖苷,旋毛生素-7-O-β-D-葡糖苷,Apigenin-7-O-Beta-D-葡萄糖醛酸,叶氏菌素-7-O-Beta-D-葡萄糖醛酸,3,5-O-二咖啡烯酸,Apigenin和胰蛋白酶显现出有效的抑制,并且它们在RLAR中的IC 50值分别为4.25,1.12,116,0.85,0.72,1.72和1.42μm。此外,这些化合物在高葡萄糖条件下抑制了大鼠晶状体中的山梨糖醇积聚,证明了它们预防山梨糖醇积累的潜力。值得注意的是,叶黄素-7-O-Beta-D-葡糖醛酸和葡萄黄素显示出抗氧化以及年龄抑制活性(这些化合物的IC 50值为3.39和6.01μm)。这些结果表明,M. Recutita提取物及其成分可能是用于预防或治疗糖尿病并发症的有前途的药剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号